S.M. Peña

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Dédée F. Murrell, S.M. Peña, P. Joly et al. · Journal of the American Academy of Dermatology · 2018 · 356 citations · Full text

Medicine, Dermatology, Pathology +1

Itch in dermatomyositis: the role of increased skin interleukin-31

Hee Joo Kim, Majid Zeidi, Diletta Bonciani et al. · British Journal of Dermatology · 2018 · 87 citations

Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

Victoria P. Werth, Emily Z. Hejazi, S.M. Peña et al. · Journal of Investigative Dermatology · 2022 · 50 citations · Full text

Randomized Clinical Trial, Refractory Skin Disease, Clinical Dermatology +4

Developing classification criteria for skin‐predominant dermatomyositis: the Delphi process

Josef Symon S. Concha, S.M. Peña, Rebecca G. Gaffney et al. · British Journal of Dermatology · 2019 · 38 citations · Full text

FRI0470 A phase 2 study of safety and efficacy of lenabasum (JBT-101), a cannabinoid receptor type 2 agonist, in refractory skin-predominant dermatomyositis

Victoria P. Werth, Emily Z. Hejazi, S.M. Peña et al. · Annals of the Rheumatic Diseases · 2018 · 21 citations · Full text